Small Molecules
Total Trials
5
As Lead Sponsor
As Collaborator
0
Total Enrollment
2,021
NCT04531150
Safety, Tolerability, and Pharmacokinetics of Single Ascending Oral Doses of INV-101 in Healthy Male and Female Subjects
Phase: Phase 1
Role: Lead Sponsor
Start: Sep 8, 2020
Completion: May 16, 2021
NCT05282446
A Study to Explore the PK and PD of INV-202 in Metabolic Syndrome
Start: Mar 1, 2022
Completion: Oct 1, 2022
NCT05514548
Phase 2 Study of INV-202 in Patients With Diabetic Kidney Disease
Phase: Phase 2
Start: Oct 19, 2022
Completion: Sep 3, 2024
NCT05891834
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
Start: Sep 8, 2023
Completion: Feb 14, 2025
NCT03176186
Xenon for Neuroprotection During Post-Cardiac Arrest Syndrome in Comatose Survivors of an Out of Hospital Cardiac Arrest
Phase: Phase 3
Start: Mar 31, 2026
Completion: May 31, 2030
Loading map...